Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib
Andrea L. Dewar(Australian Red Cross Lifeblood), A. Bruce Lyons(University of Tasmania)
Cited by 282
Related Papers
Post release immune responses of Tasmanian devils vaccinated with an experimental devil facial tumour disease vaccine
|bioRxiv (Cold Spring Harbor Laboratory)|2020|3